Sculptor Capital LP Bristol Myers Squibb CO Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $30.3 Million - $33.3 Million	-416,963 Reduced 79.3%	108,809 $8.38 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $19.4 Million - $23.3 Million	315,548 Added 150.1%	525,772 $38.4 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $11.3 Million - $13.1 Million	210,224 New	210,224 $13.1 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.